Cytosorbents Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
AVENIR CORP | 02/13/2025 | 3.09 M | $2.82 M | 3.98% | 5.68% |
SKYLANDS CAPITAL, LLC | 02/04/2025 | 2.78 M | $2.53 M | 0.95% | 5.11% |
VANGUARD GROUP INC | 02/11/2025 | 1.95 M | $1.77 M | 0.00% | 3.58% |
NEUBERGER BERMAN GROUP LLC | 02/13/2025 | 1.68 M | $1.53 M | -5.58% | 3.09% |
SARGENT INVESTMENT GROUP, LLC | 01/27/2025 | 1.25 M | $1.31 M | -23.21% | 2.29% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 1.20 M | $1.10 M | -42.50% | 2.21% |
CM MANAGEMENT, LLC | 02/07/2025 | 700,000 | $637,000 | -12.50% | 1.29% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 627,305 | $570,848 | 0.00% | 1.15% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 474,153 | $431,588 | 1.52% | 0.87% |
CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2025 | 172,649 | $167,470 | 0.00% | 0.32% |
UBS GROUP AG | 02/14/2025 | 144,925 | $131,882 | 5,536.91% | 0.27% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 122,420 | $168,715 | 0.00% | 0.22% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 108,621 | $98,845 | 100.00% | 0.20% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 88,020 | $80,098 | 10.55% | 0.16% |
KESTRA ADVISORY SERVICES, LLC | 02/10/2025 | 55,000 | $50,050 | 316.67% | 0.10% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 52,751 | $48,003 | 100.00% | 0.10% |
CABLE CAR CAPITAL LLC | 02/14/2025 | 50,000 | $45,500 | 100.00% | 0.09% |
STIFEL FINANCIAL CORP | 02/13/2025 | 48,000 | $43,680 | 6.67% | 0.09% |
KEY CLIENT FIDUCIARY ADVISORS, LLC | 01/17/2025 | 34,557 | $31,447 | 0.00% | 0.06% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 33,280 | $30,285 | 100.00% | 0.06% |
EP WEALTH ADVISORS, LLC | 02/14/2025 | 28,000 | $25,480 | 0.00% | 0.05% |
ATOMI FINANCIAL GROUP, INC. | 01/17/2025 | 27,443 | $24,973 | -19.97% | 0.05% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 25,143 | $22,880 | 100.00% | 0.05% |
XTX TOPCO LTD | 02/13/2025 | 22,792 | $20,741 | 52.43% | 0.04% |
CREATIVE PLANNING | 02/14/2025 | 21,295 | $19,378 | 0.00% | 0.04% |
SEELAUS ASSET MANAGEMENT LLC | 01/28/2025 | 18,800 | $17,108 | 0.00% | 0.03% |
SEI INVESTMENTS CO | 02/11/2025 | 15,560 | $14,140 | -14.52% | 0.03% |
COUNTRY CLUB BANK /GFN | 01/27/2025 | 15,225 | $13,702 | 0.00% | 0.03% |
MERIT FINANCIAL GROUP, LLC | 01/15/2025 | 15,000 | $13,650 | 0.00% | 0.03% |
RESOURCES INVESTMENT ADVISORS, LLC. | 02/13/2025 | 15,000 | $13,650 | 0.00% | 0.03% |
CHICAGO PARTNERS INVESTMENT GROUP LLC | 01/24/2025 | 13,614 | $13,206 | -9.15% | 0.03% |
JOHNSON INVESTMENT COUNSEL INC | 02/07/2025 | 11,534 | $10,496 | -9.93% | 0.02% |
HRT FINANCIAL LP | 02/14/2025 | 11,509 | $10,000 | 100.00% | 0.02% |
JANE STREET GROUP, LLC | 02/14/2025 | 10,147 | $9,234 | 100.00% | 0.02% |
HEXAGON CAPITAL PARTNERS LLC | 02/07/2025 | 3,333 | $3,033 | 0.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 2,095 | $1,906 | -29.72% | 0.00% |
NEW WAVE WEALTH ADVISORS LLC | 01/23/2025 | 1,631 | $1,484 | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 494 | $450 | 32.80% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 250 | $228 | 0.00% | 0.00% |
YOUR ADVOCATES LTD., LLP | 02/04/2025 | 250 | $228 | 0.00% | 0.00% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 103 | $94 | 100.00% | 0.00% |
02/06/2025 | 100 | $91 | 100.00% | 0.00% | |
PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 31 | $28 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 3 | $3 | 0.00% | 0.00% |
FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
BRADLEY FOSTER & SARGENT INC/CT | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
PRUDENTIAL FINANCIAL INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Cytosorbents Corporation institutional Ownership - FAQ's
During the previous two years, 88 institutional investors and hedge funds held shares of Cytosorbents Corporation. The most heavily invested institutionals were:
AVENIR CORP: 3.09 M
Skylands Capital, LLC: 2.78 M
VANGUARD GROUP INC: 1.95 M
Neuberger Berman Group LLC: 1.68 M
Sargent Investment Group, LLC: 1.25 M
Granahan Investment Management, LLC: 1.2 M
28.15% of Cytosorbents Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 16.67 M shares in the last 24 months. This purchase volume represents approximately $17.34 M in transactions.